The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Letter to the Editor

Letter to the Editor

May 16, 2011 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

I enjoyed reading your musings on European travel in the February TR [“Medical Renaissance”], particularly when reflecting on my own experiences as a rheumatologist in Europe, wearing two very distinctive hats. It was a rare treat to be invited to lecture at the ACR during fellowship (twice when in Mannik’s lab as a research fellow, not at all during my clinical year at The University of California, San Francisco), yet the occasions were more numerous (limited by clinic duties, attending requirements, and administrative obligation) in my years as a clinician, primarily in small group sessions with colleagues sharing clinical observations.

You Might Also Like
  • Letter to the Editor
  • Letter to the Editor
  • Letter to the Editor
Explore This Issue
May 2011
Also By This Author
  • Help Navigating ABIM Maintenance of Certification? Let the ACR Guide You!

By contrast, the world has expanded mightily during my brief tenure as clinical investigator in biotech—trips to Nottingham and Edinburgh (phase I dosage titration study of a candidate molecule for rheumatoid arthritis), upcoming EULAR meetings followed by a trip to Moscow to meet with a potential study sponsor for a parallel phase II program, investigators’ meetings this summer in Dubrovnic—to name but a few. The point has less to do with the attractions of European travel—an experience of complex aesthetic and culinary reward—than the difference of focus when attending to the goals of biotech. In distinction to academic medicine and pure patient care, I have become a project coordinator, attending to every detail of protocol construction, drug formulation, regulatory requirements for agency registration, and eventual commercial implication—none of which approached the radar screen when I ran a service in an academic hospital setting.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In Massachusetts, the relationship between church and state has become polarized to the point where academicians risk “outing” on Internet pages should they accept financial support for meetings, lectures, or even lunches from pharma. There are efforts to ameliorate this disaffected relationship, with the realization that many fellowship programs accept industry support for their operations, and might not, based on real revenue projections, be able to sustain their teaching mission were it not for such financial help. I would only say that knowing the experience of rheumatology from both sides has expanded my view of the complex universe we cohabit as peers, and my desire would be to humanize the relationship between parties, knowing that the clinical enterprise requires the efforts of biotech/pharma as much as industry in this arena requires the voice of physician advocates.

Perhaps a glass of Haut Brion with a view of Parliament over the Thames is in order.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Jonathan Krant, MD
Vice President, Clinical Research
Zalicus Inc.
Cambridge, Mass.

Pages: 1 2 | Single Page

Filed Under: Education & Training Tagged With: Education, Industry, International, rheumatologistIssue: May 2011

You Might Also Like:
  • Letter to the Editor
  • Letter to the Editor
  • Letter to the Editor
  • Letter to the Editor: Comments on July’s Ethics Forum

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)